Quantcast
Home > Quotes > SLP

Simulations Plus, Inc. Common Stock (SLP) Quote & Summary Data

SLP 
$20.16
*  
0.08
0.4%
Get SLP Alerts
*Delayed - data as of Nov. 14, 2018  -  Find a broker to begin trading SLP now
Exchange:NASDAQ
Industry: Technology
Community Rating:
View:    SLP Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
20.5
Today's High / Low
$ 20.39 / $ 20.16
Share Volume
46,575
50 Day Avg. Daily Volume
52,303
Previous Close
$ 20.24
52 Week High / Low
$ 23.95 / $ 14.25
Market Cap
350,080,093
Annualized Dividend
$ .24
Ex Dividend Date
10/31/2018
Dividend Payment Date
11/8/2018
Current Yield
1.19 %
Beta
1.2

Intraday Chart

Shares Traded

Share Volume:
46,575
50 Day Avg. Daily Volume:
52,303

P/E Ratio

P/E Ratio:
41.14
Forward P/E (1y):
38.77
Earnings Per Share (EPS):
$ 0.49

Trading Range

The current last sale of $20.16 is 41.47% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 20.39 $ 23.95
 Low: $ 20.16 $ 14.25

Company Description (as filed with the SEC)

As used in this report, each of the terms "we," "us," "our," the "Company" and "Simulations Plus" refers to Simulations Plus, Inc. and its wholly owned subsidiaries Cognigen Corporation, of Buffalo, New York, and DILIsym Services, Inc of Research Triangle Park, North Carolina, unless otherwise stated or the context otherwise requires. OVERVIEW Simulations Plus, Inc., incorporated in 1996, is a premier developer of groundbreaking drug discovery and development software for mechanistic modeling and simulation, for machine-learning-based prediction of properties of molecules solely from their structure, and is exploring the application of its machine-learning technologies in other industries, including aerospace/military and general healthcare. Our pharmaceutical/chemistry software is licensed to major pharmaceutical, biotechnology, agrochemical, and food industry companies and to regulatory agencies worldwide for use in the conduct of industry-based research.  ... More ...  


Risk Grade

Where does SLP fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 20.24
Open Date:
Nov. 14, 2018
Close Price:
$ 20.16
Close Date:
Nov. 14, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x